- Physicians Office Resource

TOX/See Drug Screen Test TCA
TOX/See - 194-5234

Device Description

A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of tricyclic antidepressant drugs in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.

Environmental Conditions

Storage Environment Temperature - Degrees Celsius

30.00
2.00

Device Sizes

No Data Available

Device Sterilization

Device Sterile: False

Sterilization Prior To Use: False

Sterilization Methods: No Data Available

Product Codes

Code: LFG

Device Name: Radioimmunoassay, Tricyclic Antidepressant Drugs

Device Class: 2

Physical State: The device may be composed of a collection apparatus and / or measurement assay.

Definition: Intended to measure any of the tricyclic antidepressant drugs in serum or urine.

Submission Type ID: 1

Review Panel: TX

Review Code: N/A

Technical Method: N

Gmp Exempt Flag: Serum or urine are collected and analyzed for the presence of antidepressant drugs.

Life Sustain Support Flag: N

Unclassified Reason: N/A

Implant Flag: N

Target Area: Serum or urine.

Regulation Number: 862.3910

Third Party Flag: Y

Medical Specialty: TX

Device Identifiers

Device Id: 00847817000768

Device Type: Primary

DeviceId Issuing Agency: GS1

Contains DI Number: N/A

Package Quantity: N/A

Package Discontinue Date: N/A

Package Status: N/A

Package Type: N/A

GMDN® is a registered trademark of The GMDN Agency. All rights reserved. The information provided on this site includes data supplied by The GMDN Agency ("GMDN Content"), which is used under licence from The GMDN Agency. Any data/information suppliers who wish to extract GMDN Content from this site in order to use it as a basis for creating and supporting commercial services such as alternative categorisation, alternative GMDN Term assignment, mapping to other categorisations or ontologies, or for AI training purposes, must first obtain an appropriate licence from The GMDN Agency. No such activity is permitted without a licence. For more information on obtaining a licence, please contact The GMDN Agency (https://www.gmdnagency.org/contact-us/). None of the GMDN content constitutes any endorsement, advice, representation or warranty about any specific medical devices that may be described by such content; and no representation or warranty is made in relation to instructions for use, suitability for any application, treatment or condition, regulatory status, or any properties of a particular medical device.